UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000008654
Receipt No. R000010170
Scientific Title The clinical role of BAFF and APRIL in the human pancreatic cancer.
Date of disclosure of the study information 2012/08/09
Last modified on 2019/08/16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The clinical role of BAFF and APRIL in the human pancreatic cancer.
Acronym Study of BAFF and APRIL in pancreatic cancer
Scientific Title The clinical role of BAFF and APRIL in the human pancreatic cancer.
Scientific Title:Acronym Study of BAFF and APRIL in pancreatic cancer
Region
Japan

Condition
Condition pancreatic cancer
Classification by specialty
Medicine in general Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Identifying the clinical roles of BAFF and APRIL in pancreatic cancer.
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Clinical roles
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Subjects who were taken a blood sample or pancreatic tissue by internal or surgical treatment.
Key exclusion criteria Subjects who are considered that taking the samples will make worse their prognosis.
Target sample size 100

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yoichi Hiasa
Organization Ehime University Graduate School of Medicine
Division name Department of Gastroenterology and Metabology
Zip code
Address Shitsukawa, Toon, Ehime 791-0295, Japan
TEL +81-89-960-5308
Email hiasa@m.ehime-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Mitsuhito Koizumi
Organization Ehime University Graduate School of Medicine
Division name Department of Gastroenterology and Metabology
Zip code
Address Shitsukawa, Toon, Ehime 791-0295, Japan
TEL +81-89-960-5308
Homepage URL
Email koizumim08@gmail.com

Sponsor
Institute Ehime University Graduate School of Medicine
Institute
Department

Funding Source
Organization a Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science, from the Ministry of Education, Culture, Sports, Science and Technology, Japan
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 08 Month 09 Day

Related information
URL releasing protocol
Publication of results Partially published

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2011 Year 08 Month 01 Day
Date of IRB
2011 Year 08 Month 01 Day
Anticipated trial start date
2011 Year 08 Month 01 Day
Last follow-up date
2019 Year 08 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Identifying the clinical roles of BAFF and APRIL in pancreatic cancer.

Management information
Registered date
2012 Year 08 Month 09 Day
Last modified on
2019 Year 08 Month 16 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010170

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.